As Delta Variant Surges, More Biopharma Companies Mandate COVID-19 Vaccines

As the work force begins to return to the office, life science companies are having to take their stance on vaccine policy. Some have chosen a strict mandate, others a mandate with options and others have yet to issue an edict.

With just over half the U.S. population fully vaccinated against COVID-19, the pandemic continues to emit an air of politics over science as our country remains as polarized as ever.